{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "CitationSubset": [], "OtherAbstract": [], "KeywordList": [["CD3", "Candida", "Immunosuppression", "Ozone", "Tongue"]], "GeneralNote": [], "OtherID": [], "InvestigatorList": [], "PMID": "30069501", "DateRevised": {"Year": "2020", "Month": "10", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "11"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bbrep.2018.06.007"], "Journal": {"ISSN": "2405-5808", "JournalIssue": {"Volume": "15", "PubDate": {"Year": "2018", "Month": "Sep"}}, "Title": "Biochemistry and biophysics reports", "ISOAbbreviation": "Biochem Biophys Rep"}, "ArticleTitle": "Biological assessment of ozone therapy on experimental oral candidiasis in immunosuppressed rats.", "Pagination": {"StartPage": "57", "EndPage": "60", "MedlinePgn": "57-60"}, "Abstract": {"AbstractText": ["Immunosuppressive drugs can compromise local or general defense mechanisms and can lead to oral candidiasis. Ozone therapy has a wide range of applications in almost every field of dentistry. Its unique properties include immunostimulant, analgesic, antihypnotic, detoxicating, and antimicrobial actions. Sixty male healthy rats were immunosuppressed with dexamethasone in their drinking water one week before candida infection. The animals were divided into four equal groups. Rats of group 1 were kept without any manipulation and those of group II were given oral inoculums of C. albicans on the dorsal surface of the tongue. Group III rats were handled as group II and instead the rats were treated by daily mycostatin drops local applicator as a routine treatment. Meanwhile, group IV rats were handled as group II and instead the rats were received daily intraperitoneal injection of 1\u202fcm<sup>3</sup> of ozone oxygen gas mixture with concentration of ozone 70\u202f\u03bcg/cm<sup>3</sup>. After two weeks, all rats were euthanized and tongue specimens were prepared for histological staining with Haematoxylin & Eosin and CD3 immunohistochemical staining. Histological examination revealed that treatment with ozone therapy lead to gradual decrease in lingual papillary atrophy and invasion of candida yeast. Immunohistochemical study showed significant decrease in CD3 counting. We can conclude that ozone acts as an excellent fungicidal agent also, ozone is capable of alerting the immune system."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Oral Biology, Faculty of Dentistry, Mansoura University, 35516 El-Gomhoria Street, Egypt."}], "Identifier": [], "LastName": "Amin", "ForeName": "Laila E", "Initials": "LE"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Biochem Biophys Rep", "NlmUniqueID": "101660999", "ISSNLinking": "2405-5808"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Challacombe S.J. Immunologic aspects of oral candidiasis. Oral Surg. Oral Med. Oral Pathol. 1994;78(2):202\u2013210.", "ArticleIdList": ["7936590"]}, {"Citation": "Odds F.C. Bailliere Tindall; 1988. Candida and Candidosis: A Review and Bibliography."}, {"Citation": "Flaitz C.M., Hicks M.J. Oral candidiasis in children with immune suppression: clinical appearance and therapeutic considerations. ASDC J. Dent. Child. 1999;66(3):161\u2013166. (54)", "ArticleIdList": ["10476353"]}, {"Citation": "Freire-Garabal M., N\u00fa\u00f1ez M., Balboa J. Effects of amphetamine on development of oral candidiasis in rats. Clin. Diagn. Lab. Immunol. 1999;6(4):530\u2013533.", "ArticleIdList": ["PMC95721", "10391856"]}, {"Citation": "Lopez-Ribot J.L., McAtee R.K., Perea S., Kirkpatrick W.R. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 1999;43(7):1621\u20131630.", "ArticleIdList": ["PMC89334", "10390213"]}, {"Citation": "Meitner S.W., Bowen W.H., Haidaris C. Oral and esophageal Candida albicans infection in hyposalivatory rats. Infect. Immun. 1990;58(7):2228\u20132236.", "ArticleIdList": ["PMC258801", "2194965"]}, {"Citation": "Allen C.M. Animal models of oral candidiasis: a review. Oral Surg. Oral Med. Oral Pathol. 1994;78(2):216\u2013221.", "ArticleIdList": ["7936592"]}, {"Citation": "Jorge A., Totti M., Almeida O. Effect of sialoadenectomy on the carriage of Candida albicans in the mouths of rats. J. Oral. Pathol. Med. 1993;22(3):138\u2013140.", "ArticleIdList": ["8487220"]}, {"Citation": "Ponte E., Tabaj D., Maglione M. Diabetes mellitus and oral disease. Acta Diabetol. 2001;38(2):57\u201362.", "ArticleIdList": ["11757802"]}, {"Citation": "Ebelle R.E., Mouokeu R.S., Assam J.P.A., Hopogap M.L., Masoohe A.M., Hiol M.C., Tientcheu R., Ngono N.R.A., Etoa F.X. Potentiating antifungal activity of fluconazole or nystatin with methanol bark extract of harungana madagascariensis stem bark. IJPPR. 2017;9(5):674\u2013679."}, {"Citation": "Tiwari S., Avinash A., Katiyar S. Dental applications of ozone therapy: a review of literature. Saudi J. Dent. Res. 2017;8(1):105\u2013111."}, {"Citation": "Garg R., Tandon S. Ozone: a new face of dentistry. Internet J. Dent. Sci. 2009;7(2)"}, {"Citation": "Kagan J. Are you ready for this\u2013ozone therapy. Ozone Inf. Clin. [Online] 2003"}, {"Citation": "Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediat. Inflamm. 2004;13(1):3\u201311.", "ArticleIdList": ["PMC1781533", "15203558"]}, {"Citation": "Jones J., Russell C., Young C. Tetracycline and the colonization and infection of the mouths of germ-free and conventionalized rats with Candida albicans. J. Antimicrob. Chemother. 1976;2(3):247\u2013253.", "ArticleIdList": ["789323"]}, {"Citation": "Reed M., Scragg M., Williams D. In vivo effects of Candida albicans products on rat oral epithelium. J. Oral. Pathol. Med. 1990;19(7):326\u2013329.", "ArticleIdList": ["2231438"]}, {"Citation": "Salem N.A., Assaf N., Ismail M.F. Ozone therapy in ethidium bromide-induced demyelination in rats: possible protective effect. Cell. Mol. Neurobiol. 2016;36(6):943\u2013954.", "ArticleIdList": ["26467344"]}, {"Citation": "J Kuryszko J.A.M., Madej P. Ultrastructural studies on organs of cadmium-poisoned rats treated with oxygen-ozone mixture. Arch. Vet. Pol. 1995;35(1\u20132):109\u2013115.", "ArticleIdList": ["9071458"]}, {"Citation": "Russell C., Jones J. Effects of oral inoculation of Candida albicans in tetracycline-treated rats. J. Med. Microbiol. 1973;6(3):275\u2013279.", "ArticleIdList": ["4580060"]}, {"Citation": "Broadwater W.T., Hoehn R., King P. Sensitivity of three selected bacterial species to ozone. Appl. Microbiol. 1973;26(3):391\u2013393.", "ArticleIdList": ["PMC379797", "4201643"]}, {"Citation": "Bocci V. Autohaemotherapy after treatment of blood with ozone. A reappraisal. J. Int. Med. Res. 1994;22(3):131\u2013144.", "ArticleIdList": ["8088420"]}, {"Citation": "Huth K.C., Jakob F.M., Saugel B. Effect of ozone on oral cells compared with established antimicrobials. Eur. J. Oral Sci. 2006;114(5):435\u2013440.", "ArticleIdList": ["17026511"]}, {"Citation": "Vartivarian S.E., Anaissie E.J., Bodey G.P. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin. Infect. Dis. 1993;17(Suppl. 2):S487\u2013S491.", "ArticleIdList": ["8274615"]}, {"Citation": "Kosonen J., Luhtala M., Viander M. Candida albicans\u2010specific lymphoproliferative and cytokine (IL\u20104 and IFN\u2010\u03b3) responses in atopic eczema dermatitis syndrome. Evidence of CD4/CD8 and CD3/CD16+ CD56 ratio elevations in vitro. Exp. Dermatol. 2005;14(7):551\u2013558.", "ArticleIdList": ["15946244"]}, {"Citation": "Bocci V.A. Scientific and medical aspects of ozone therapy. State of the art. Arch. Med. Res. 2006;37(4):425\u2013435.", "ArticleIdList": ["16624639"]}, {"Citation": "Werkmeister H. Subatmospheric 02/03 treatment of therapy-resistant wounds and ulcerations. OzoNachrichten. 1985;4:53\u201359."}, {"Citation": "Bocci V. OZONE: Springer; 2010. The Potential Toxicity of Ozone: Side Effects and Contraindications of Ozonetherapy; pp. 75\u201384."}, {"Citation": "Schwartz A., S\u00e1nchez G.M. Ozone therapy and its scientific foundations. Rev. Esp. Ozonoterapia. 2012;2(1):199\u2013232."}, {"Citation": "Nogales C.G., Ferreira M.B., Lage-Marques J.L. Comparison of the antimicrobial activity of three different concentrations of aqueous ozone on Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococcus faecalis\u2013in vitro study. Rev. Esp. Ozonoterapia. 2014;4(1):9\u201315."}, {"Citation": "Babior B.M., Takeuchi C., Ruedi J. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc. Natl. Acad. Sci. USA. 2003;100(6):3031\u20133034.", "ArticleIdList": ["PMC152239", "12601145"]}, {"Citation": "S\u00e1nchez G.M., Re L., Perez-Davison G., Delaporte R.H. Las aplicaciones m\u00e9dicas de los aceites ozonizados, actualizaci\u00f3n. Rev. Esp. Ozonoterapia. 2012;2(1):121\u2013139."}, {"Citation": "Montevecchi M., Dorigo A., Cricca M., Checchi L. Comparison of the antibacterial activity of an ozonated oil with chlorhexidine digluconate and povidone-iodine. A disk diffusion test. New Microbiol. 2013;36:289\u2013302.", "ArticleIdList": ["23912871"]}]}], "History": [{"Year": "2018", "Month": "3", "Day": "29"}, {"Year": "2018", "Month": "6", "Day": "20"}, {"Year": "2018", "Month": "6", "Day": "28"}, {"Year": "2018", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "3", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "7", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["30069501", "PMC6067064", "10.1016/j.bbrep.2018.06.007", "S2405-5808(18)30068-2"]}}]}